Jun 01, 2020
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells
May 21, 2020
Global Stem Cells Group Announces the Launch of its New Division VITA NOVAS
Apr 27, 2020
Cellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in Canada
Apr 02, 2020
Cellect Biotechnology Receives New Patent Allowance in China
Apr 01, 2020
FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS
Mar 04, 2020
First Patient Dosed in Phase I Clinical Trial using RoosterBio's Cellular Starting Materials
Feb 21, 2020
R3 Stem Cell Teams Up With Veterans in Pain (VIP) to Offer Regenerative Therapies for Burn Pit Syndrome
Feb 20, 2020
R3 Stem Cell Heroes Program Performs Complimentary Regenerative Therapies on 70 Veterans in 2019
Jan 17, 2020
6th Perinatal Stem Cell Society Congress | Salt Lake City, United States - March 4th-6th, 2020
Jan 09, 2020
R3 Stem Cell Now Offering Complimentary Cryogenic Freezer to Partner Clinics
Dec 04, 2019
R3 Stem Cell Training Course Scheduled for Jan 24-25, 2020 Now Open for Registration
Nov 07, 2019
R3 Stem Cell Online Training Course Now 50% Off Through January 1, 2020
Nov 01, 2019
AIVITA Biomedical to Present at Upcoming Regenerative Medicine, Oncology and Investor Conferences in November
Oct 23, 2019
R3 Stem Cell Aesthetics Training Scheduled for Nov 15-16, 2019 in Scottsdale AZ
Oct 21, 2019
The global regenerative medicine market size is expected to reach USD 5.60 billion by 2025, expanding at a CAGR of 11.6% over the forecast period
Oct 14, 2019
R3 Stem Cell Announces Online Training Course Enrollment
Sep 30, 2019
Australian Patent Office Grants Patent Covering RoosterBio's Novel Compositions and Formulations for Ready-to-Print (RTP) Cells
Sep 19, 2019
R3 Stem Cell Now Offering Exosome Training at Aesthetics Courses
Sep 04, 2019
R3 Stem Cell Provider Training Now Enrolling for October 18-19, 2019 Course
Aug 26, 2019
For Faster Research on Immunotherapies: PromoCell to Offer HLA-typed Human Primary Cells